390
Views
4
CrossRef citations to date
0
Altmetric
Reviews

Natalizumab in multiple sclerosis: discontinuation, progressive multifocal leukoencephalopathy and possible use in children

, , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Marinella Clerico, Carlo Alberto Artusi, Alessandra Di Liberto, Simona Rolla, Valentina Bardina, Pierangelo Barbero, Stefania Federica De Mercanti & Luca Durelli. (2017) Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis. Expert Opinion on Drug Safety 16:8, pages 963-972.
Read now

Articles from other publishers (3)

Aliénor de Chalus, Mélanie Taveira & Kumaran Deiva. (2021) Pediatric onset multiple sclerosis: Future challenge for early diagnosis and treatment. La Presse Médicale 50:2, pages 104069.
Crossref
Elena Uleri, Gabriele Ibba, Claudia Piu, Maurizio Caocci, Stefania Leoni, Giannina Arru, Caterina Serra, GianPietro Sechi & Antonina Dolei. (2016) JC polyomavirus expression and bell-shaped regulation of its SF2/ASF suppressor during the follow-up of multiple sclerosis patients treated with natalizumab. Journal of NeuroVirology 23:2, pages 226-238.
Crossref
Sandra Söderholm, Yu Fu, Lana Gaelings, Sergey Belanov, Laxman Yetukuri, Mikhail Berlinkov, Anton Cheltsov, Simon Anders, Tero Aittokallio, Tuula Nyman, Sampsa Matikainen & Denis Kainov. (2016) Multi-Omics Studies towards Novel Modulators of Influenza A Virus–Host Interaction. Viruses 8:10, pages 269.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.